Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy

American Journal of Nephrology

Volumn 25, Issue 6, 2005, Pages 579-585

  Tang, Zheng ^a   Ren, Hongqi ^a   Yang, Guang ^a   Chen, Huiping ^a   Zhou, Hong ^a   Zeng, Caihong ^a   Liu, Zhihong ^a   Li, Leishi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Glomeruli; Preeclamptic nephropathy; Renal biopsy; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY PARENCHYMA; MULTIPARA; NEPHRECTOMY; NULLIPARA; PATHOLOGY; PEROXIDASE ANTIPEROXIDASE COMPLEX; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL;

ADULT; CELL PROLIFERATION; ENDOTHELIUM; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29144487376     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089265     Document Type: Article

References (29)

1. Roberts WG, Palade G: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-2379.
2. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004;65:2003-2017.
3. Ferrara N, Gerber HP: The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 2001;106:148-156.
4. Neufeld G, Cohen T, Gengrinovitch S, et al: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
5. Bailey E, Bottomley MJ, Westwells S, et al: Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridization. J Clin Pathol 1999;52:735-738.
6. Horita Y, Miyazaki M, Koji T, et al: Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis. Nephrol Dial Transplant 1998;13:2519-2528.
7. de Vriese AS, Tilton RG, Elger M, Stephan CC, et al: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001;12:993-1000.
8. Cha DR, Kang YS, Han SY, et al: Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol 2004;183:183-194.
9. Tsuchida K, Makita Z, Yamagishi S, et al: Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999;42:579-588.
10. Cha DR, Kim NH, Yoon JW, et al: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int Suppl 2000;77:S104-S112.
11. Bortoloso E, Del Prete D, Dalla Vestra M, et al: Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol 2004;150:799-807.
12. Su H, Zhu Z, Zhang C, et al: The effect of vascular endothelial growth factor and its receptor in kidney lesion of rats with preeclampsia. J Huazhong Univ Sci Tech (Health Sci) 2003;32:46-50.
13. Eremina V, Sood M, Haigh J, et al: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003;111:707-716.
14. ACOG Committee on Obstetric Practice: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
15. Gartner HV, Sammoun A, Wehrmann M, et al: Preeclamptic nephropathy - An endothelial lesion. A morphological study with a review of the literature. Eur J Obstet Gynecol Reprod Biol 1998;77:11-27.
16. Strevens H, Wide-Swensson D, Hansen A, et al: Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003;110:831-836.
17. Hunter A, Aitkenhead M, Caldwell C, et al: Serum levels of vascular endothelial growth factor in preeclampsia and normotensive pregnancy. Hypertension 2000;36:965-969.
18. McKeeman GC, Ardill JE, Caldwell CM, et al: Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004;191:1240-1246.
19. Levine RJ, Maynard SE, Qian C, et al: Circulating angiogenic factors. N Engl J Med 2004;350;672-683.
20. Davison JM, Homuth V, Jeyabalan A, et al: New aspects in the pathophysiology of pre-eclampsia. J Am Soc Nephrol 2004;15:2440-2448.
21. Svedas E, Islam KB, Nisell H, et al: Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol 2003;188:168-176.
22. Maynard SE, Min JY, Merchan J, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension and proteinuria in pre-eclampsia. J Clin Invest 2003;111:649-658.
23. Chaiworapongsa T, Romero R, Espinoza J: Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004;190:1541-1547.
24. Ren H, Tang Z, Liu Z, et al: Clinical and pathological analysis in patients with preeclamptic nephropathy. J Nephrol Transplant 2005;14:131-135.
25. Yamagishi S, Inagaki Y, Okamoto T, et al: Advanced glycation end product induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 2002;277:20309-20315.
26. Tang K, Breen EC, Wagner H: HIF and VEGF relationships in response to hypoxia and sciatic nerve stimulation in rat gastrocnemius. Respir Physiol Neurobiol 2004;144:71-80.
27. Wang Y, Gu Y, Zhang YP, et al: Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004;190:817-824.
28. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-2376.
29. Brown LF, Berse B, Winer J, et al: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992;42:1457-1465.